1O'Shaughnessy J, Twelves C, Aapro M. Treatment for anthracycline-pretreated metastatic breast cancer [J]. Oncologist, 2002, 7 (Suppl 6):4-12.
2Singal PK, Iliskovic N. Doxombicin-induced cardiomyopathy[J]. N Engl J Med, 1998, 339(13):900-905.
3Gianni L, Herman EH, Lipshuhz SE, et al. Anthracycline cardiotoxicity: from bench to bedside [J]. J Clin Oncol, 2008, 26(22):3777-3784.
4Mordente A, Meucci E, Silvestrini A, et al. New developments in anthracycline-induced cardiotoxicity [J]. Curr Med Chem, 2009, 16(13):1656-1672.
5Abu-Khalaf MM, HaMs L. Anthracycline-induced cardiotoxicity: risk assessment and management [J]. Oncology (Williston Park), 2009, 23(3):239, 244, 252.
6Von Hoff DD, Layard MW, Basa P, et al. Risk factors for doxorubicin-induced congestive heart failure [J]. Ann Intern Med, 1979, 91(5):710-717.
7Ryberg M, Nielsen D, Cortese G, et al. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients [J]. J Natl Cancer Inst, 2008, 100(15):1058-1067.
8Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials[J]. Cancer, 2003, 97(11):2869-2879.
9Goethals I, De Winter O, De Boudt P, et al. The clinical value of nuclear medicine in the assessment of irradiation- induced and anthracycline-associated cardiac damage[J]. Ann Oncol, 2002, 13(9):1331-1339.
10Gennari A, Salvadori B, Donati S, et al. Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors[J]. J Clin Oncol, 1999, 17(11):3596-3602.
3Maisel S,Koon J,Krishnaswamy P,et al.Utility of BNP as a rapid,point of care test for screening patients under-going echocardiography to determine left ventricular dysfunction[J].Am Heart J,2001,14(30):367.
4Lee HS,Son CB,Shin SH,et al.Clinical correlation between brain natriutetic peptide and anthracyclin-induced cardiac toxicity[J].Cancer Res Treat,2008,40(3):121-126.
5Okumura H,Iuchi K,Yoshida T,et al.Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity[J].Acta Haematol,2000,104(4):158-163.
6Feola M,Garrone O,Occelli M,et al.Cardiotoxicity after anthracycline chemotherapy in breast carcinoma:Effects on left ventricular ejection fraction,troponin I and brain natriuretic peptide[J].Int J Cardiol,2011,148(2):194-198.
7Raschi E,Vasina V,Ursino MG,et al.Anticancer drugs and cardiotoxicity:Insights and perspective in the era of largeted therapy[J].Pharmacol Ther,2010,125 (2):196-218.
